Mitoxantrone Injection, Solution, Concentrate
Product Images NDC 61703-343

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Mitoxantrone (NDC 61703-343). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Mitoxantron 01)

FDA Label Image

Mitoxantron 01a

The text describes a chemical compound with four nitrogen and carbon atoms, and two oxygen and hydrogen atoms. The compound can be reacted with hydrochloric acid (HCl) to produce two molecules of hydrochloride (HCI).*

FDA Label Image

Logo (Mitoxantron 02)

FDA Label Image

Mitoxantron 02a

FDA Label Image

Principal Display Panel (10 mL Vial Label)

FDA Label Image

Principal Display Panel (10 mL Vial Carton)

This is a description of a medication called "Mitoxantrone Injection, USP". It is a cytotoxic agent and is used for intravenous infusion. Each milliliter contains Mitoxantrone Hydrochloride equivalent to 2 mg of the drug. It also contains other ingredients such as sodium chloride, sodium metabisulfite, sodium acetate, acetic acid, and water. Open vials can only be stored for 7 days at room temperature or 14 days under refrigeration. It should not be frozen and contains no preservative. The medication is distributed by Hospira, Inc., based in Lake Forest, IL.*

FDA Label Image

Principal Display Panel (12.5 mL Vial Label)

FDA Label Image

Principal Display Panel (12.5 mL Vial Carton)

This is a medication that contains Mioxantrone Hydrochloride and is used for intravenous infusion in patients. The dosage and other information regarding the medication can be found in the package insert. It should be stored at 20°C-25°C and should not be frozen. Open vials can be stored for longer periods under certain temperature conditions. The medication is a cytotoxic agent and does not contain any preservative. The manufacturer of the medication is located in Lake Forest, IL, USA.*

FDA Label Image

Principal Display Panel (15 mL Vial Label)

FDA Label Image

Principal Display Panel (15 mL Vial Carton)

MitoXANTRONE is a cytotoxic agent used for intravenous infusion. Each mL of the concentrate contains Witoantrone Hydrochloride equivalent to 2 mg mitontrone free base, along with other additives. The recommended dosage should be referred to on the package insert. The vials must be stored at 20% 25°C (68°- 77°F), and open vials may be stored for up to 7 days at 15°- 25°C (59°- 77°F) or 14 days under refrigeration. The medication guide should be provided to each patient. Hospia, Inc. in Lake Forest, IL distributes this drug.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.